BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -33.72 Million | -3.93 Million | -27.06 Million | -7.62 Million | -13.39 Million |
| Net Income | -32.6 Million | -4.05 Million | -30.65 Million | -9.29 Million | -14.8 Million |
| Depreciation & Amortization | 1.65 Million | 1.4 Million | 1.6 Million | 1.46 Million | 1.24 Million |
| Deferred income taxes | -6.25 Million | -5.24 Million | -2.48 Million | -2.73 Million | - |
| Stock-based compensation | 292.54 Thousand | 1.78 Million | 1.13 Million | -41 Thousand | 40.47 Thousand |
| Change in working capital | -1 Million | -647.01 Thousand | 1.87 Million | 145.63 Thousand | 90.16 Thousand |
| Other non-cash items | 1.53 Million | 2.82 Million | 1.44 Million | 2.83 Million | 2.47 Million |
| Investing Cash Flow | 5.89 Million | -60.05 Million | -51.47 Million | -815.82 Thousand | -410.1 Thousand |
| Investments in PPE | -1.31 Million | -1.18 Million | -1.45 Million | -815.82 Thousand | -410.1 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | -58.87 Million | -50.01 Million | - | - |
| Sales/Maturities of investments | 7.2 Million | - | - | - | - |
| Other Investing Activities | -1.00 | -1.00 | -50.21 Million | - | - |
| Financing Cash Flow | 2.28 Million | 26.11 Million | 98.52 Million | 78.49 Million | 22.9 Million |
| Debt repayment | -775.47 Thousand | -609.76 Thousand | -654.88 Thousand | -707.44 Thousand | -606.41 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 3.05 Million | 26.72 Million | 99.17 Million | 79.2 Million | 23.5 Million |
| Other Financing Activities | -771.83 Thousand | -607.57 Thousand | -652.23 Thousand | -708.67 Thousand | -606.66 Thousand |
| Accounts receivables | 232.24 Thousand | -3.69 Million | 2.57 Million | -723.77 Thousand | -340.23 Thousand |
| Accounts payables | -1.2 Million | 2.54 Million | 709.48 Thousand | 710.98 Thousand | 689.98 Thousand |
| Inventory | -338 Thousand | 510.16 Thousand | -1.4 Million | 158.41 Thousand | -259.58 Thousand |
| Other working capital | 304.64 Thousand | 2.55 Million | -1.00 | -1.00 | -1.00 |
| Cash at beginning of period | 49.18 Million | 100.27 Million | 88.79 Million | 16.44 Million | 7.76 Million |
| Cash at end of period | 25.61 Million | 49.18 Million | 100.27 Million | 88.79 Million | 16.44 Million |
| Capital Expenditure | -1.31 Million | -1.18 Million | -1.45 Million | -815.82 Thousand | -410.1 Thousand |
| Effect of forex changes on cash | 1.98 Million | -13.21 Million | -1.00 | 2.3 Million | -1.00 |
| Net cash flow / Change in cash | -23.56 Million | -51.08 Million | 11.47 Million | 72.35 Million | 8.68 Million |
| Free Cash Flow | -35.03 Million | -5.11 Million | -28.52 Million | -8.44 Million | -13.8 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.52 Million | -148.32 Million | -7.28 Million | -9.58 Million | -32.6 Million | -6.48 Million |
| Depreciation & Amortization | 473.53 Thousand | 4.88 Million | 440 Thousand | 450.07 Thousand | 1.65 Million | 386.23 Thousand |
| Deferred income taxes | - | - | - | -1.51 Million | -6.25 Million | -1.77 Million |
| Stock-based compensation | - | 206.28 Thousand | 856 Thousand | 617 Thousand | 2.95 Million | 1 Million |
| Change in working capital | -1.71 Million | 8.38 Million | 1.22 Million | 2.2 Million | -1 Million | -3.07 Million |
| Other non-cash items | 1.26 Million | 249.88 Thousand | 341.75 Thousand | 688.62 Thousand | 1.53 Million | 255.9 Thousand |
| Investing Cash Flow | 34.2 Million | 116.41 Million | 25.24 Million | -25.03 Million | 5.89 Million | 11.29 Million |
| Investments in PPE | -193.84 Thousand | -4.92 Million | -213.32 Thousand | -271.81 Thousand | -1.31 Million | -250.7 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 34.39 Million | 11.39 Million | 25.45 Million | -24.76 Million | 7.2 Million | 11.54 Million |
| Other Investing Activities | - | 11.45 Million | 25.52 Million | -1.00 | -1.00 | -1.00 |
| Financing Cash Flow | -204.52 Thousand | -2.07 Million | -192.4 Thousand | -202.92 Thousand | 2.28 Million | -176.38 Thousand |
| Debt repayment | - | -195.62 Thousand | -192.92 Thousand | -203.88 Thousand | -775.47 Thousand | -177.02 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 3.05 Million | - |
| Other Financing Activities | -204.52 Thousand | -194.65 Thousand | - | - | -771.83 Thousand | - |
| Accounts receivables | - | - | - | 233.33 Thousand | 232.24 Thousand | - |
| Accounts payables | - | - | - | - | -1.2 Million | - |
| Inventory | - | - | - | -33.51 Thousand | -338 Thousand | - |
| Other working capital | -1.71 Million | 791.08 Thousand | 1.22 Million | 2.01 Million | 304.64 Thousand | -3.08 Million |
| Cash at beginning of period | 44.15 Million | 469.14 Million | 25.61 Million | 53.78 Million | 49.18 Million | 52.66 Million |
| Cash at end of period | 70.3 Million | 470.25 Million | 43.81 Million | 25.61 Million | 25.61 Million | 53.78 Million |
| Capital Expenditure | -193.84 Thousand | -4.92 Million | -213.32 Thousand | -271.81 Thousand | -1.31 Million | -250.7 Thousand |
| Effect of forex changes on cash | - | - | - | 4.21 Million | 1.98 Million | -1.00 |
| Net cash flow / Change in cash | 26.14 Million | 1.11 Million | 18.2 Million | -28.17 Million | -23.56 Million | 1.12 Million |
| Free Cash Flow | -9.7 Million | -124.13 Million | -6.36 Million | -7.41 Million | -35.03 Million | -9.94 Million |
AV-B
SHILPAMED
VFRM
9511
IDIA
AL-PA